MB
Mercury Bio, Inc.
SEC filingBiotechnology · Santa Fe, NM
Amount raised$2.4Msold at filing
Total offering$8M$5.6M still open
Investors in the raise6count reported to the SEC
FiledOct 24, 2025first sale Sep 30, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alex KoglinDirector
John TomesDirector
Mike RiceDirector
Paul LaurExecutive Officer, Director
Steve KiziukDirector
Dana BarnardDirector
Bruce McCormickExecutive Officer, Director
Kevin McDonaldDirector
Executive officers, directors and promoters as listed on the Form D.